[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review

April 2021 | 25 pages | ID: P8E6AA0EAF9EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Phoenix Pharmahandel GmbH & Co KG (Phoenix Group) is a pharmaceutical trading company which offers integrated supply chain solutions for pharmaceutical companies. It undertakes wholesale distribution of pharmaceuticals to pharmacy retail business. The company distributes health products and drugs to pharmacies, doctors and medical institutions. It also provides specialised services for pharmaceutical companies and supports pharmacies with cooperation programmes, goods management systems, and in the area of patient advice. The company operations are spread across Albania, Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Hungary, Italy, Kosovo, Serbia, the UK, Norway, Poland, Sweden, Lithuania, Macedonia, Switzerland, the Netherlands, and Latvia. Phoenix Group is headquartered in Mannheim, Baden-Wurttemberg, Germany.

Phoenix Pharmahandel GmbH & Co KG Key Recent Developments

Dec 15,2020: Blokable unveils Phoenix Rising, the world's first Vertically Integrated Modular housing development, providing high-quality, energy efficient housing, at less than half the Seattle region's average cost per door
Jun 24,2020: Certara launches version 8.3 of Phoenix biosimulation software for drug development
Jan 27,2020: Phoenix Realty Group completes over $700m of investment activity in Q4

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Phoenix Pharmahandel GmbH & Co KG - Key Facts
Phoenix Pharmahandel GmbH & Co KG - Key Employees
Phoenix Pharmahandel GmbH & Co KG - Key Employee Biographies
Phoenix Pharmahandel GmbH & Co KG - Major Products and Services
Phoenix Pharmahandel GmbH & Co KG - History
Phoenix Pharmahandel GmbH & Co KG - Company Statement
Phoenix Pharmahandel GmbH & Co KG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Phoenix Pharmahandel GmbH & Co KG - Business Description
Geographical Segment: Eastern Europe
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Northern Europe
Performance
Geographical Segment: Western Europe
Performance
Phoenix Pharmahandel GmbH & Co KG - Corporate Strategy
Phoenix Pharmahandel GmbH & Co KG - SWOT Analysis
SWOT Analysis - Overview
Phoenix Pharmahandel GmbH & Co KG - Strengths
Phoenix Pharmahandel GmbH & Co KG - Weaknesses
Phoenix Pharmahandel GmbH & Co KG - Opportunities
Phoenix Pharmahandel GmbH & Co KG - Threats
Phoenix Pharmahandel GmbH & Co KG - Key Competitors
Phoenix Pharmahandel GmbH & Co KG, Recent Deals Summary

SECTION 3 – COMPANY’S RECENT DEVELOPMENTS

Dec 15, 2020: Blokable unveils Phoenix Rising, the world's first Vertically Integrated Modular housing development, providing high-quality, energy efficient housing, at less than half the Seattle region's average cost per door
Jun 24, 2020: Certara launches version 8.3 of Phoenix biosimulation software for drug development
Jan 27, 2020: Phoenix Realty Group completes over $700m of investment activity in Q4

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Phoenix Pharmahandel GmbH & Co KG, Key Facts
Phoenix Pharmahandel GmbH & Co KG, Key Employees
Phoenix Pharmahandel GmbH & Co KG, Key Employee Biographies
Phoenix Pharmahandel GmbH & Co KG, Major Products and Services
Phoenix Pharmahandel GmbH & Co KG, History
Phoenix Pharmahandel GmbH & Co KG, Subsidiaries
Phoenix Pharmahandel GmbH & Co KG, Key Competitors
Phoenix Pharmahandel GmbH & Co KG, Recent Deals Summary


More Publications